25 results
·
22ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
PRO OSTEON 200R RESORBABLE BONE GRAFT SUBSTITUTE, MODELS 2RG051, 2RG101, 2RG151, 2RG201, 2RG301, 2RG050, 2RG100, 2RG150,
FDA 510(k)
FDA Class 2
·Orthopedic
Nobel
FDA UDI
Preat Corporation·00842092167069·NobelBiocare™ Tri-Lobe-compatible RP Non-Engagi...
PowerPICC
FDA UDI
Bard Access Systems, Inc.·00801741101182·Catheter Placement Kit
Sledgehammer
FDA UDI
Keystone Industries·H66810005151·SC 25 lb Pwd Clear
PedFlex Flexible Nailing System
FDA UDI
ORTHOPEDIATRICS CORP.·00841132119594·ø1.5mm x 300mm Round Tip Flexible IM Nail
PedFlex Flexible Nailing System
FDA UDI
ORTHOPEDIATRICS CORP.·00841132198261·Ø1.5 MM X 300 MM ROUND TIP FLEXIBLE IM NAIL
BARCOMED 2MP2
FDA 510(k)
FDA Class 2
·Radiology
RETIC CHEX LINEARITY
FDA 510(k)
FDA Class 2
·Hematology
DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM
FDA Adverse Event
Malfunction
·DEXCOM, INC.·Product code QBJ·January 2, 2025
DREAMSTATION CPAP PRO
FDA Adverse Event
Malfunction
·RESPIRONICS, INC.·Product code BZD·January 8, 2025
CAPSUREFIX
FDA Adverse Event
Death
·MPRI·Product code DTB·March 12, 2013
ZENITH FLEX AAA ENDOVASCULAR GRAFT ILIAC LEG
FDA Adverse Event
Malfunction
·COOK, INC.·Product code MIH·February 1, 2011
UNICEL DXC 800 PRO SYNCHRON CLINICAL SYSTEMS
FDA Adverse Event
Malfunction
·BECKMAN COULTER, INC.·Product code JJE·February 13, 2008
DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM
FDA Adverse Event
Malfunction
·DEXCOM, INC.·Product code PQF·April 29, 2018
DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM
FDA Adverse Event
Malfunction
·DEXCOM, INC.·Product code PQF·April 29, 2018
DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM
FDA Adverse Event
Malfunction
·DEXCOM, INC.·Product code PQF·April 28, 2018
LIFEGLOBAL MEDIA
FDA Adverse Event
Injury
·COOPERSURGICAL, INC.·Product code MQL·July 10, 2025
LIFEPAK 15 V4/Masimo Rainbow Sensors: Masimo RD rainbow Adt 8 SpCO, SpO2, and SpMet, Adult Adhesive Sensors REF 11996-000515 Masimo LNCS-II rainbow DCI 8 SpCO, Adult Reusable Sensor REF 11996-000519 Masimo LNCS-II rainbow DCI 8 SpCO, Pediatric Reusable Sensor REF 11996-000520 The LIFEPAK 15 Monitor/Defibrillator (LP15) is a complete acute cardiac care response system designed for basic life support (BLS) and advanced life support (ALS) patient management protocols. RD rainbow" 8 SpCO sensors are indicated for the continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO2), pulse rate, carboxyhemoglobin saturation (SpCO), and methemoglobin saturation (SpMet) for use with adult, pediatric, infant, and neonatal patients during both no motion and motion conditions, and for patients who are well or poorly perfused in hospitals, hospital-type facilities, mobile, and home environments.
FDA Recall
Open, Classified
·Physio-Control, Inc.·Product code MKJ·January 21, 2025
Smiths Medical, Medfusion¿ Syringe Infusion Pump, Model 4000, Software Version V1.0 & V1.1, Reorder Numbers 4000-0100-50, 4000-0100-95, 4000-0101-50, 4000-0101-51, and 4000-0101-78. Designed for use in care areas for the administration of fluids requiring precisely controlled infusion rates.
FDA Enforcement
Class I
·Terminated·Smiths Medical ASD, Inc.·August 8, 2012
LIFEPAK 15 V4/Masimo Rainbow Sensors: Masimo¿ RD rainbow Adt 8¿ SpCO, SpO2, and SpMet, Adult Adhesive Sensors REF 11996-000515 Masimo¿ LNCS-II rainbow¿ DCI 8¿ SpCO, Adult Reusable Sensor REF 11996-000519 Masimo¿ LNCS-II rainbow¿ DCI 8¿ SpCO, Pediatric Reusable Sensor REF 11996-000520 The LIFEPAK¿ 15 Monitor/Defibrillator (LP15) is a complete acute cardiac care response system designed for basic life support (BLS) and advanced life support (ALS) patient management protocols. RD rainbow" 8¿ SpCO sensors are indicated for the continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO2), pulse rate, carboxyhemoglobin saturation (SpCO¿), and methemoglobin saturation (SpMet¿) for use with adult, pediatric, infant, and neonatal patients during both no motion and motion conditions, and for patients who are well or poorly perfused in hospitals, hospital-type facilities, mobile, and home environments.
FDA Enforcement
Class II
·Ongoing·Physio-Control, Inc.·February 26, 2025